Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Immunity|November 3, 2009
T helper 17 cells promote cytotoxic T cell activation in tumor immunityNatalia Martin-Orozco, Pawel Muranski, Yeonseok Chung, et al.
Cancer Research|March 17, 2007
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signalingYangbing Zhao, Maria R Parkhurst, Zhili Zheng, et al.
Plos Pathogens|May 30, 2009
Viral sequestration of antigen subverts cross presentation to CD8(+) T cellsEric F Tewalt, Jean M Grant, Erica L Granger, et al.
European Journal of Immunology|January 6, 2010
IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cellsBeatrice Bolinger, Daniel Engeler, Philippe Krebs, et al.
Blood|May 28, 2009
Type 17 CD8+ T cells display enhanced antitumor immunityChristian S Hinrichs, Andrew Kaiser, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Blood|August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependentLuca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
The Journal of Clinical Investigation|August 18, 2004
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of toleranceZhiya Yu, Marc R Theoret, Christopher E Touloukian, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Immunity|November 3, 2009
T helper 17 cells promote cytotoxic T cell activation in tumor immunityNatalia Martin-Orozco, Pawel Muranski, Yeonseok Chung, et al.
Cancer Research|March 17, 2007
Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signalingYangbing Zhao, Maria R Parkhurst, Zhili Zheng, et al.
Plos Pathogens|May 30, 2009
Viral sequestration of antigen subverts cross presentation to CD8(+) T cellsEric F Tewalt, Jean M Grant, Erica L Granger, et al.
European Journal of Immunology|January 6, 2010
IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cellsBeatrice Bolinger, Daniel Engeler, Philippe Krebs, et al.
Blood|May 28, 2009
Type 17 CD8+ T cells display enhanced antitumor immunityChristian S Hinrichs, Andrew Kaiser, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceShawn M Jensen, Christopher G Twitty, Levi D Maston, et al.
Blood|August 3, 2006
CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependentLuca Gattinoni, Anju Ranganathan, Deborah R Surman, et al.
The Journal of Clinical Investigation|August 18, 2004
Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of toleranceZhiya Yu, Marc R Theoret, Christopher E Touloukian, et al.
Cancer Research|November 17, 2005
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editingLi-Xin Wang, Rui Li, Guojun Yang, et al.
Pageof 26